Please provide your email address to receive an email when new articles are posted on . Research into effective treatments for myopic progression expands beyond contact lenses and involves atropine, ...

Waldwick, New Jersey / Syndication Cloud / January 23, 2026 / A2Z Eyecare P.C Key Takeaways Myopia and astigmatism frequently ...

Myopia, or nearsightedness, is at an all-time high among children in the US. Globally, half the population is expected to be nearsighted by 2050. Ophthalmologists are gravely concerned that these ...

Dilating eyedrops may delay ― and perhaps even prevent ― the onset of myopia in children, according to findings from a study published today in JAMA. The study was conducted by researchers in Hong ...

A Change.org petition with more than 800 signatures is calling on the FDA to approve low-dose atropine to slow the ...

A study that focused on children aged 5 to 12 years who lived in the United States found no difference between atropine 0.01% and placebo in treating myopia progression. Atropine 0.01% was no more ...

Use of low-dose atropine eyedrops (concentration 0.01%) was no better than placebo at slowing myopia (nearsightedness) progression and elongation of the eye among children treated for two years, ...

A Prescription Drug User Fee Act target date of October 23, 2025 has been assigned to the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

Children with myopia using 0.05% atropine eye drops had less myopia progression and/or less axial elongation compared with those using placebo or 0.01% atropine, though they had higher rates of ...

In a cohort of over 1.2 million Taiwanese children followed up for at least 5 years, those with myopia had a higher risk for ocular problems than those without the condition. However, among children ...